Wedbush Securities’s Quoin Pharmaceuticals QNRX Stock Holding History

Wedbush Securities’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2	Closed	-$84K	–	960
2020 Q3	$84K	Buy	+2	New	+$116K	0.01%	846
2020 Q1	–	Sell	-1	Closed	-$52K	–	981
2019 Q4	$52K	Sell	1 -1	-50%	-$51.3K	﹤0.01%	963
2019 Q3	$81K	Buy	2 +1	+100%	+$54.3K	0.01%	910
2019 Q2	$59K	Hold	1	–	–	0.01%	939
2019 Q1	$66K	Buy	+1	New	+$179K	0.01%	880

Other funds holding QNRX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wedbush Securities's QNRX Position: Q4 2020 in Review

Wedbush Securities sold out of Quoin Pharmaceuticals (QNRX) in Q4 2020, closing a stake of 2 shares — an estimated $84K sold.

Wedbush Securities first reported a position in QNRX in Q1 2019 and held it in 5 quarters. The position peaked at $84K in Q3 2020. 1 fund tracked by Wall St. Rank holds QNRX as of Q4 2020.

Wedbush Securities reported no remaining Quoin Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Wedbush Securities sold 2 Quoin Pharmaceuticals shares in Q4 2020, an estimated $84K.
Wedbush Securities first reported a position in Quoin Pharmaceuticals in Q1 2019 and held it in 5 quarters.
Wedbush Securities's Quoin Pharmaceuticals position peaked at $84K in Q3 2020.
1 fund tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q4 2020.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.